
doi: 10.1111/pai.13619
pmid: 35080292
pmc: PMC9305411
handle: 11570/3239587 , 20.500.11769/523761 , 11571/1460146
doi: 10.1111/pai.13619
pmid: 35080292
pmc: PMC9305411
handle: 11570/3239587 , 20.500.11769/523761 , 11571/1460146
AbstractRecently, type 2 inflammation has been recognized as one of the most critical factors participating in the pathogenesis of cystic fibrosis (CF). On the one hand, type 2 inflammation restores tissue homeostasis and contributes to the resolution of inflammation following an injury. On the other hand, type 2 response‐activated immune cells may become dysregulated or chronically activated, causing tissue fibrosis. Among the type 2 cytokine‐driven inflammatory pathways, the transforming growth factor β (TGFβ), interleukin (IL)‐17, IL‐33, and IL‐13 have been identified as essential mediators in patients suffering from CF. Given their critical role, we firmly believe that an adequate comprehension of the type 2‐mediated pathways can identify attractive targets to decrease pharmacologically the inflammation and fibrosis occurring in the pulmonary tissue of patients suffering from CF.
Inflammation, Cystic Fibrosis, adult, type 2 inflammation, adult, children, cystic fibrosis, tissue fibrosis, type 2 inflammation, Cytokines, Humans, Inflammation, Inflammation Mediators, Lung, Cystic Fibrosis, 610, cystic fibrosis, tissue fibrosi, Special Issue: 2021 Update From The Italian Society Of Pediatric Allergy And Immunology, children, tissue fibrosis, 616, Cytokines, Humans, Inflammation Mediators, Cytokine, Inflammation Mediator, Lung, cystic fibrosi, Human
Inflammation, Cystic Fibrosis, adult, type 2 inflammation, adult, children, cystic fibrosis, tissue fibrosis, type 2 inflammation, Cytokines, Humans, Inflammation, Inflammation Mediators, Lung, Cystic Fibrosis, 610, cystic fibrosis, tissue fibrosi, Special Issue: 2021 Update From The Italian Society Of Pediatric Allergy And Immunology, children, tissue fibrosis, 616, Cytokines, Humans, Inflammation Mediators, Cytokine, Inflammation Mediator, Lung, cystic fibrosi, Human
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 24 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
